Therapeutic Switching of Metformin Using Heteroleptic Cu(II) and Zn(II) Complexes: A Combined Experimental and Computational Study
Abstract
Ligands of the antidiabetic drug metformin and the natural flavonoid chrysin were used to synthesize Cu-(II) and Zn-(II) heteroleptic complexes. Metal complexation was used to repurpose metformin against the breast cancer cell line MCF-7. Structural information on the metal complexes was acquired using UV-vis absorption spectroscopy, FTIR, HRMS, TGA/DTA, XRD, SEM-EDX, molar conductance analysis, and time-dependent density functional theory (TDDFT). Accordingly, we proposed that the structure of complex 1 was [Cu-(C4H11N5)-(C15H9O4)-(C2H3O2)], with a square pyramidal geometry, while complex 2 was [Zn-(C4H11N5)-(C15H9O4)]-C2H3O2 and exhibited a tetrahedral geometry. The IC50 values were 18.93 and 43.31 μM for complexes 1 and 2, respectively, compared to the positive control cisplatin (IC50 = 18.62 μM). The cancer cells' morphology changed from epithelial to a round shape, and the cell density decreased upon treatment, confirming the potential of the metal complexes to induce apoptosis. Computationally, the biological significance of the metal complexes was inferred from quantum chemical descriptors and molecular docking analysis. The band gap energies of the metal complexes were 2.964 and 3.648 eV for complexes 1 and 2, respectively, compared to those of metformin (5.988 eV) and chrysin (4.403 eV). Moreover, molecular docking simulations against estrogen receptor alpha (ERα; PDB: 5GS4) revealed a binding energy of -5.69 kcal mol-1 and an inhibition constant (K i) of 51.37 μM…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.